V. I. Materii
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
V. I. Materii has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- H. A. Sarkisyan
Pirogov Russian National Research Medical University
3 shared publications - Petr V. Shumilov
Pirogov Russian National Research Medical University
3 shared publications - I. M. Burlakova
Pirogov Russian National Research Medical University
2 shared publications - Yulia V. Zhirkova
Pirogov Russian National Research Medical University
2 shared publications A. A. Komarova
Pirogov Russian National Research Medical University
1 shared publication- D. A. Romanova
Children's Clinical Hospital № 9 named after G.N. Speransky
1 shared publication
Latest Publications
- Open Access
- 27 November 2025
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 24 (4) , 61-67
A clinical case of vertical transmission of herpes types 3 and 6 from an infected mother to a newborn
Over the past 20 years, human herpes virus infections have continued to occupy leading positions in statistics. Frequent infection of newborns with several herpes viruses at once causes an atypical course of the infectious process. The development of neonatal chickenpox is associated with maternal infection with Varicella Zoster Virus in late pregnancy, which poses a serious threat to the life and health of the newborn. The carriage of the chromosomally integrated form of herpes type 6 by parents causes the transmission of the genetic material of the virus in several generations. The high probability of transmission of infectious agents from mother to newborn necessitates the development of algorithms for pregravid preparation that increase the probability of the birth of a healthy full-term child. The aim of the work was to present a clinical case of vertical transmission of herpes viruses types 3 and 6 from mother to newborn, with the implementation of a combined herpesvirus infection already in the early neonatal period. Materials and methods : an analysis of the medical records of a child who was hospitalized in a children's multidisciplinary hospital with a diagnosis of neonatal varicella was conducted; a review of modern literature, an analysis of statistical and regulatory documents using the PubMed, NIH, Scopus, scientific library eLibrary.RU, ResearchGate databases were conducted.
- 27 November 2025
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 24 (4) , 61-67
Open AccessA clinical case of vertical transmission of herpes types 3 and 6 from an infected mother to a newborn
Over the past 20 years, human herpes virus infections have continued to occupy leading positions in statistics. Frequent infection of newborns with several herpes viruses at once causes an atypical course of the infectious process. The development of neonatal chickenpox is associated with maternal infection with Varicella Zoster Virus in late pregnancy, which poses a serious threat to the life and health of the newborn. The carriage of the chromosomally integrated form of herpes type 6 by parents causes the transmission of the genetic material of the virus in several generations. The high probability of transmission of infectious agents from mother to newborn necessitates the development of algorithms for pregravid preparation that increase the probability of the birth of a healthy full-term child. The aim of the work was to present a clinical case of vertical transmission of herpes viruses types 3 and 6 from mother to newborn, with the implementation of a combined herpesvirus infection already in the early neonatal period. Materials and methods : an analysis of the medical records of a child who was hospitalized in a children's multidisciplinary hospital with a diagnosis of neonatal varicella was conducted; a review of modern literature, an analysis of statistical and regulatory documents using the PubMed, NIH, Scopus, scientific library eLibrary.RU, ResearchGate databases were conducted.
- 27 April 2025
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 70 (2/2) , 90-100
Features of hemorrhagic disease in newborns
Hemorrhagic disorder of the newborn (or Vitamin K Deficiency Bleeding, VKDB) is a pathological condition caused by a deficiency of vitamin K, which is necessary for the synthesis of blood clotting factors, in children aged 8 days to 6 months. Vitamin K Deficiency Bleeding manifests as bleeding from various localizations. The late form of disease is typically diagnosed after the first week of life and can present as severe intracranial hemorrhages, which in turn can lead not only to residual neurological symptoms but also to fatal outcomes. This condition is observed in newborns who have not received prophylactic vitamin K administration at the delivery and are exclusively breastfed. This underscores the necessity for prevention, timely diagnosis, and treatment. Diagnosis is based on the medical history, clinical picture, and laboratory blood clotting analyses. The updated clinical recommendations for Vitamin K Deficiency Bleeding prevention have been implemented globally and in Russia, but the concerns of management children with late form of Vitamin K Deficiency Bleeding are still relevant. This article presents three clinical cases of full-term infants with late forms of Vitamin K Deficiency Bleeding. They did not receive prophylactic vitamin K administration and were exclusively breastfed. Special attention is given to the diagnosis and treatment of neurological disorders associated with intracranial hemorrhage, as well as the importance of timely prevention to avoid complications.
- 27 April 2025
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 70 (2/2) , 90-100
Features of hemorrhagic disease in newborns
Hemorrhagic disorder of the newborn (or Vitamin K Deficiency Bleeding, VKDB) is a pathological condition caused by a deficiency of vitamin K, which is necessary for the synthesis of blood clotting factors, in children aged 8 days to 6 months. Vitamin K Deficiency Bleeding manifests as bleeding from various localizations. The late form of disease is typically diagnosed after the first week of life and can present as severe intracranial hemorrhages, which in turn can lead not only to residual neurological symptoms but also to fatal outcomes. This condition is observed in newborns who have not received prophylactic vitamin K administration at the delivery and are exclusively breastfed. This underscores the necessity for prevention, timely diagnosis, and treatment. Diagnosis is based on the medical history, clinical picture, and laboratory blood clotting analyses. The updated clinical recommendations for Vitamin K Deficiency Bleeding prevention have been implemented globally and in Russia, but the concerns of management children with late form of Vitamin K Deficiency Bleeding are still relevant. This article presents three clinical cases of full-term infants with late forms of Vitamin K Deficiency Bleeding. They did not receive prophylactic vitamin K administration and were exclusively breastfed. Special attention is given to the diagnosis and treatment of neurological disorders associated with intracranial hemorrhage, as well as the importance of timely prevention to avoid complications.
- 1 January 2025
- Published by Dynasty Publishing House in Voprosy detskoj dietologii
- Vol. 23 (4)
2-hydroxyglutaric aciduria in the practice of neonatologists and pediatricians: possibilities for early diagnosis and treatment
2-hydroxyglutaric aciduria (ICD-10 code E72.8: Other specified disorders of amino-acid metabolism) is a group of rare metabolic disorders resulting from the accumulation of α-ketoglutarate derivatives in mitochondria: D- and L-enantiomers of 2-hydroxyglutaric acid. This pathology is caused by a wide range of mutations in the genes of mitochondrial enzymes, which explains the existence of several subtypes of the disease in the described group. Over the 45 years since the first mention of 2-hydroxyglutaric aciduria, nearly 500 cases have been reported worldwide. 2-hydroxyglutaric aciduria leads to multisystemic disorders, primarily neurological, severe disability, or death, which determines the importance of early diagnosis. The disease is not included in neonatal screening, but certain similarities between its clinical and laboratory manifestations and various acidemias and other metabolic disorders, as well as their severe consequences and outcomes, necessitate further study and systematization of knowledge about this pathology. This article describes current approaches to the diagnosis and treatment of 2-hydroxyglutaric aciduria in newborns and young children. Key words: inherited metabolic disorders, aciduria, 2-hydroxyglutaric acid, 2-hydroxyglutaric aciduria, D-2-hydroxyglutaric aciduria types I and II, L-2-hydroxyglutaric aciduria
- 1 January 2025
- Published by Dynasty Publishing House in Voprosy detskoj dietologii
- Vol. 23 (4)
2-hydroxyglutaric aciduria in the practice of neonatologists and pediatricians: possibilities for early diagnosis and treatment
2-hydroxyglutaric aciduria (ICD-10 code E72.8: Other specified disorders of amino-acid metabolism) is a group of rare metabolic disorders resulting from the accumulation of α-ketoglutarate derivatives in mitochondria: D- and L-enantiomers of 2-hydroxyglutaric acid. This pathology is caused by a wide range of mutations in the genes of mitochondrial enzymes, which explains the existence of several subtypes of the disease in the described group. Over the 45 years since the first mention of 2-hydroxyglutaric aciduria, nearly 500 cases have been reported worldwide. 2-hydroxyglutaric aciduria leads to multisystemic disorders, primarily neurological, severe disability, or death, which determines the importance of early diagnosis. The disease is not included in neonatal screening, but certain similarities between its clinical and laboratory manifestations and various acidemias and other metabolic disorders, as well as their severe consequences and outcomes, necessitate further study and systematization of knowledge about this pathology. This article describes current approaches to the diagnosis and treatment of 2-hydroxyglutaric aciduria in newborns and young children. Key words: inherited metabolic disorders, aciduria, 2-hydroxyglutaric acid, 2-hydroxyglutaric aciduria, D-2-hydroxyglutaric aciduria types I and II, L-2-hydroxyglutaric aciduria